ASX - By Stock
|
AVR |
Re:
Ann: Court Approval to Hold Scheme Meetings & Booklet Registered
|
|
Mawson11
|
144 |
52K |
1 |
09/09/24 |
09/09/24 |
ASX - By Stock
|
144
|
52K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Half Yearly Report and Accounts
|
|
Mawson11
|
36 |
14K |
4 |
28/08/24 |
28/08/24 |
ASX - By Stock
|
36
|
14K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Half Yearly Report and Accounts
|
|
Mawson11
|
36 |
14K |
5 |
28/08/24 |
28/08/24 |
ASX - By Stock
|
36
|
14K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Video
|
|
Mawson11
|
47 |
11K |
1 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
47
|
11K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
Mawson11
|
81 |
22K |
14 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
81
|
22K
|
14
|
|
ASX - By Stock
|
VRX |
Re:
Ann: Arrowsmith North Updated BFS
|
|
Mawson11
|
235 |
56K |
1 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
235
|
56K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Data Update on First-in-Human Study of DurAVR at NY Valves
|
|
Mawson11
|
45 |
12K |
0 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
45
|
12K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Data Update on First-in-Human Study of DurAVR at NY Valves
|
|
Mawson11
|
45 |
12K |
3 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
45
|
12K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Data Update on First-in-Human Study of DurAVR at NY Valves
|
|
Mawson11
|
45 |
12K |
7 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
45
|
12K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
2024 AGM Presentation
|
|
Mawson11
|
3 |
1.7K |
6 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
3
|
1.7K
|
6
|
|
ASX - By Stock
|
VRX |
Re:
Ann: Arrowsmith North Environmental Approval Update
|
|
Mawson11
|
265 |
70K |
5 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
265
|
70K
|
5
|
|
ASX - By Stock
|
VRX |
Re:
Ann: VRX Investor Webinar
|
|
Mawson11
|
149 |
33K |
6 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
149
|
33K
|
6
|
|
ASX - By Stock
|
VRX |
Re:
Long suffering holder
|
|
Mawson11
|
346 |
94K |
8 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
346
|
94K
|
8
|
|
ASX - By Stock
|
VRX |
Re:
Long suffering holder
|
|
Mawson11
|
346 |
94K |
2 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
346
|
94K
|
2
|
|
ASX - By Stock
|
VRX |
Re:
Ann: Results of Entitlement Offer
|
|
Mawson11
|
75 |
19K |
4 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
75
|
19K
|
4
|
|
ASX - By Stock
|
VRX |
Re:
Ann: Change of Director's Interest Notice
|
|
Mawson11
|
28 |
8.1K |
1 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
28
|
8.1K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: First in Human TAVR in TAVR in SAVR using DurAVR
|
|
Mawson11
|
7 |
2.4K |
6 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
7
|
2.4K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
AGM 2024 questions - please submit here.
|
|
Mawson11
|
93 |
30K |
13 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
93
|
30K
|
13
|
|
ASX - By Stock
|
AVR |
Re:
Published paper that mentions DurAVR
|
|
Mawson11
|
14 |
5.6K |
6 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
14
|
5.6K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Mawson11
|
11 |
3.7K |
12 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
11
|
3.7K
|
12
|
|
ASX - By Stock
|
VRX |
Re:
Ann: Trading Halt
|
|
Mawson11
|
72 |
22K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
72
|
22K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Preparing for Pivotal Trial
|
|
Mawson11
|
10 |
2.9K |
3 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
10
|
2.9K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Cap Raise - Nasdaq listing
|
|
Mawson11
|
27 |
8.3K |
1 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
27
|
8.3K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
AVR results presentation at CRT 24 Washington DC 9th to 12th March
|
|
Mawson11
|
65 |
25K |
3 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
65
|
25K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
price control
|
|
Mawson11
|
13 |
6.8K |
9 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
13
|
6.8K
|
9
|
|
ASX - By Stock
|
VRX |
Re:
Daily price prediction thread
|
|
Mawson11
|
10K |
2.9M |
2 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
10K
|
2.9M
|
2
|
|
ASX - By Stock
|
VRX |
Re:
Daily price prediction thread
|
|
Mawson11
|
10K |
2.9M |
2 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
10K
|
2.9M
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
Mawson11
|
200 |
59K |
1 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
200
|
59K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
Mawson11
|
200 |
59K |
5 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
200
|
59K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Change in substantial holding
|
|
Mawson11
|
6 |
2.1K |
0 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
6
|
2.1K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Update on Equity Raising
|
|
Mawson11
|
28 |
10K |
1 |
16/12/23 |
16/12/23 |
ASX - By Stock
|
28
|
10K
|
1
|
|
ASX - By Stock
|
VRX |
Re:
Daily price prediction thread
|
|
Mawson11
|
10K |
2.9M |
2 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
10K
|
2.9M
|
2
|
|
ASX - By Stock
|
AVR |
Re:
TAVR MARKET Superiority
|
|
Mawson11
|
87 |
30K |
2 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
87
|
30K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Capital Raise
|
|
Mawson11
|
116 |
32K |
2 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
116
|
32K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Cleveland Clinic has enrolled patients in EFS
|
|
Mawson11
|
39 |
11K |
16 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
39
|
11K
|
16
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Exceptional Results in Second Valve-in-Valve Case
|
|
Mawson11
|
42 |
13K |
6 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
42
|
13K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Price
|
|
Mawson11
|
37 |
14K |
1 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
37
|
14K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
AVR CEO - Proactive interview 14/06/23
|
|
Mawson11
|
14 |
6.1K |
1 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
14
|
6.1K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
AVR CEO - Proactive interview 14/06/23
|
|
Mawson11
|
14 |
6.1K |
6 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
14
|
6.1K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Video discussion on EuroPCR2023 presentation
|
|
Mawson11
|
12 |
4.0K |
10 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
12
|
4.0K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Patent for Transcatheter Heart Valve Replacement Technology
|
|
Mawson11
|
25 |
11K |
6 |
13/04/23 |
13/04/23 |
ASX - By Stock
|
25
|
11K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Becoming a substantial holder
|
|
Mawson11
|
18 |
5.1K |
11 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
18
|
5.1K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
Abbot Article
|
|
Mawson11
|
11 |
3.6K |
1 |
03/03/23 |
03/03/23 |
ASX - By Stock
|
11
|
3.6K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Settlement of $35M Capital Raising Transaction
|
|
Mawson11
|
205 |
68K |
0 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
205
|
68K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: $35M Capital Raise
|
|
Mawson11
|
147 |
39K |
1 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
147
|
39K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
The latent value in the Adapt treatment process.
|
|
Mawson11
|
30 |
12K |
23 |
26/01/23 |
26/01/23 |
ASX - By Stock
|
30
|
12K
|
23
|
|
ASX - By Stock
|
AVR |
Re:
Competitor FDA approval
|
|
Mawson11
|
18 |
8.3K |
10 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
18
|
8.3K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
New Edwards CEO
|
|
Mawson11
|
95 |
29K |
0 |
11/12/22 |
11/12/22 |
ASX - By Stock
|
95
|
29K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
CEO interview on Proactive Investors
|
|
Mawson11
|
15 |
6.2K |
4 |
09/12/22 |
09/12/22 |
ASX - By Stock
|
15
|
6.2K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
CEO interview on Proactive Investors
|
|
Mawson11
|
15 |
6.2K |
6 |
06/12/22 |
06/12/22 |
ASX - By Stock
|
15
|
6.2K
|
6
|
|